Molecular Biosystems Inc.

Molecular Biosystems, Inc. is a leader in the development, manufacture and sale of ultrasound contrast imaging agents. These contrast agents are used primarily to improve the real-time images ("moving pictures") of organs and body structures, especially the heart, obtained through ultrasound examinations. MBI's products are designed to increase the diagnosticusefulness of ultrasound examinations through enhanced visualization of structures and vasculature, and to reduce the need for diagnostic procedures that may be more expensive, time-consuming, or invasive. MBI is the first and only company to obtain marketing approval from the United States Food and Drug Administration ("FDA") for ultrasound contrast agents, having gained approvals for ALBUNEX-Registered Trademark-_in 1994 and for OPTISON-TM- (the Company's second-generation agent) in 1997. OPTISON, a significant improvement over ALBUNEX in terms of efficacy, is used to detect heart disease by assessing blood flow within the heart chambers and by identifying the location of the chamber borders and the movement of the chamber walls ("cardiac function").

Contact Details: 10070 Barnes Canyon Road San Diego CA 92121 United States of America Tel: 619 452 0681 Fax: Email: WWW: www.biosystems.com/

Loading...

BioNews Results for Molecular Biosystems Inc.:
Microbix gets Canadian nod to market urokinase injection	PharmaBiz:  Nov 12 2009 9:25AM Matching: molecular biosystems inc
BioTrove poised for acquisition, new spin-out	Mass High Tech:  Nov 11 2009 2:35PM Matching: molecular biosystems inc
Microbix Biosystems receives Health Canada's marketing and export approval for KINLYTIC	News-Medical.Net:  Nov 11 2009 5:41AM Matching: molecular biosystems inc
Microbix Receives Approval To Market Thrombolytic Agent Kinlytic (urokinase) In Canada	Pharma Live:  Nov 11 2009 3:14AM Matching: molecular biosystems inc
Microbix Receives Approval To Market Thrombolytic Agent Kinlytic(TM) (urokinase) In Canada	SmartBrief:  Nov 11 2009 12:46AM Matching: molecular biosystems inc
Promote your company here: BioNewsCast - Press Release Distribution	→View more Molecular Biosystems Inc. news.

Molecular Biosystems Inc. Patents:
US Patent No.	Title
4588525	Prodrug compounds for dermal application
5362866	Oligonucleotide polymeric support system with an oxidation cleavable link
5373846	Method of ultrasonic imaging of body cavities
5385147	Method of ultrasonic imaging of the gastrointestinal tract and upper abdominal organs using an orally administered negative contrast medium
5401493	Perfluoro-1H,-1H-neopentyl containing contrast agents and method to use same
→View more Molecular Biosystems Inc. patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 1427 times since April 2007, the link to the organisation's website has been followed 290 times

Recent Search Terms used to find this page: molecular biosystems inc | Molecular Biosystems | contrast agents Albunex by Molecular Biosystems Inc | molecular biosystems | Molecular Biosystems | Molecular Biosystems | molecular biosystems | molecular biosystems | Molecular Biosystems | molecular biosystems | .

Search for more companies in San Diego

Search for more companies in CA

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Molecular Biosystems Inc.